For US & Australia: Available after minimum commitment is fulfilled
Semaglutide is not contraindicated in Crohn's disease, but safety depends on individual factors including disease activity, nutritional status, and presence of complications like strictures
Discussing your personalized genetic contextif testing is availablecan inform whether standard titration schedules align with your expected biology, or whether modified escalation might be prudent
L.EverettA
Key Takeaways: As of October 2, 2024, Lillys tirzepatide, the active ingredient in both Zepbound and Mounjaro was removed from FDAs Drug Shortage database and listed as resolved
The pathogenesis of hepatic encephalopathy is unknown, but there is general agreement that, in the majority of instances, it reflects a metabolic rather than a structural disorder of the brain